


To provide long-term capital growth.
| Name | % Net Assets |
|---|---|
| Nestle S.A. | 3.0% |
| Gilead Sciences | 2.5% |
| Google Inc. Cl A | 2.5% |
| Eutelsat Communications | 2.5% |
| Shoppers Drug Mart Corp. | 2.5% |
| Thermo Fisher Scientific | 2.4% |
| Praxair | 2.4% |
| CSL | 2.2% |
| Compass Group | 2.2% |
| Ameriprise Financial | 2.1% |
| Key | % Net Assets |
|---|---|
| 3.0% | |
| 2.5% | |
| 2.5% | |
| 2.5% | |
| 89.5% |
| Date | 19-Aug-2025 |
|---|---|
| NAV | 368.20p |
| Currency | GBP |
| Change | 0.000p |
| % | n/a |
| YTD change | 11.71p |
| YTD % | 3.28% |
| Fund Inception | 14/02/2000 |
|---|---|
| Fund Manager | Paula Allen |
| TER | 1.14 (15-Apr-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 5.25% |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.06 |
You are here: research